دورية أكاديمية
Inferior vena cava filter thromboprophylaxis in surgical cancer patients.
| العنوان: | Inferior vena cava filter thromboprophylaxis in surgical cancer patients. |
|---|---|
| المؤلفون: | Makary MS; Division of Vascular and Interventional Radiology, Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA., Koso M; Division of Vascular and Interventional Radiology, Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA., Yoder M; Division of Vascular and Interventional Radiology, Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA. |
| المصدر: | Journal of surgical oncology [J Surg Oncol] 2024 Aug; Vol. 130 (2), pp. 257-264. Date of Electronic Publication: 2024 Jun 12. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0222643 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9098 (Electronic) Linking ISSN: 00224790 NLM ISO Abbreviation: J Surg Oncol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: <2005-> : Hoboken, NJ : Wiley-Liss Original Publication: New York, Plenum. |
| مواضيع طبية MeSH: | Vena Cava Filters* , Neoplasms*/surgery , Neoplasms*/complications , Venous Thromboembolism*/prevention & control , Venous Thromboembolism*/etiology , Pulmonary Embolism*/prevention & control , Pulmonary Embolism*/etiology , Pulmonary Embolism*/epidemiology, Humans ; Female ; Male ; Retrospective Studies ; Middle Aged ; Aged ; Adult ; Venous Thrombosis/prevention & control ; Venous Thrombosis/etiology ; Postoperative Complications/prevention & control ; Postoperative Complications/epidemiology ; Aged, 80 and over ; Risk Factors |
| مستخلص: | Background and Objectives: This study evaluated the utilization and outcomes of inferior vena cava (IVC) filters as thromboprophylaxis in cancer patients undergoing surgery. Methods: This single-center retrospective study analyzed baseline patient characteristics and clinical outcomes of surgical cancer patients who received perioperative prophylactic IVC filters. Primary clinical endpoints included venous thromboembolism (VTE) incidence and filter complications. A statistical correlative analysis was conducted to identify risk factors related to pulmonary embolism (PE), deep vein thrombosis (DVT), and filter thrombi, as well as advanced technique filter removal and mortality at 6 months. Results: A total of 252 surgical oncology patients (median age, 59; female 51%) received IVC filters for the perioperative prevention of PE. Primary surgical sites included spine (n = 91, 36%), orthopedic extremity/joint (n = 49, 19%), genitourinary (n = 47, 19%), brain/cranial (n = 40, 16%), abdominal (n = 18, 7%), multisite (n = 4, 2%), and chest (n = 3, 1%). Moreover, 15% of patients experienced DVTs in the postplacement preretrieval period, while 2% (n = 6) of patients experienced definitive PEs. A total of 36% of IVC filters were ultimately retrieved, with an average filter dwell time of 7.4 months. Complications occurred in one retrieval. Conclusion: Prophylactic perioperative IVC filters in surgical cancer patients resulted in minimal complications while ultimately resulting in a low incidence of PE. (© 2024 The Author(s). Journal of Surgical Oncology published by Wiley Periodicals LLC.) |
| References: | Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism. Am J Prev Med. 2010;38(4 suppl):S495‐S501. doi:10.1016/j.amepre.2009.12.017. Khan F, Tritschler T, Kahn SR, Rodger MA. Venous thromboembolism. Lancet. 2021;398(10294):64‐77. doi:10.1016/S0140-6736(20)32658-1. Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC. Epidemiology of cancer‐associated venous thrombosis. Blood. 2013;122(10):1712‐1723. doi:10.1182/blood-2013-04-460121. Khorana AA. Venous thromboembolism and prognosis in cancer. Thromb Res. 2010;125(6):490‐493. doi:10.1016/j.thromres.2009.12.023. Marshall A, Levine M, Hill C, et al. Treatment of cancer‐associated venous thromboembolism: 12‐month outcomes of the placebo versus rivaroxaban randomization of the SELECT‐D trial (SELECT‐D: 12m). J Thromb Haemost. 2020;18(4):905‐915. doi:10.1111/jth.14752. Key NS, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol. 2020;38(5):496‐520. doi:10.1200/JCO.19.01461. Spyropoulos AC, Brotman DJ, Amin AN, Deitelzweig SB, Jaffer AK, McKean SC. Prevention of venous thromboembolism in the cancer surgery patient. Cleve Clin J Med. 2008;75(suppl 3):S17. doi:10.3949/ccjm.75.suppl_3.s17. Streiff MB, Holmstrom B, Angelini D, et al. Cancer‐associated venous thromboembolic disease, version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw. 2021;19(10):1181‐1201. doi:10.6004/jnccn.2021.0047. Lyman GH, Carrier M, Ay C, et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 2021;5(4):927‐974. doi:10.1182/bloodadvances.2020003442. White R, Zhou H, Romano P. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost. 2003;90(3):446‐455. doi:10.1160/TH03-03-0152. Heit JA, O'Fallon WM, Petterson TM, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population‐based study. Arch Intern Med. 2002;162(11):1245‐1248. doi:10.1001/archinte.162.11.1245. Prandoni P, Lensing AWA, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002;100(10):3484‐3488. doi:10.1182/blood-2002-01-0108. Balabhadra S, Kuban JD, Lee S, et al. Association of inferior vena cava filter placement with rates of pulmonary embolism in patients with cancer and acute lower extremity deep venous thrombosis. JAMA Netw Open. 2020;3(7):e2011079. doi:10.1001/jamanetworkopen.2020.11079. Pandhi M, Desai K, Ryu R, Lewandowski R. The role of inferior vena cava filters in cancer patients. Semin Intervent Radiol. 2016;33(2):71‐74. doi:10.1055/s-0036-1581090. Mikhail S, Hannan L, Pishvaian MJ, Kessler C. Retrievable inferior vena cava filters in patients with cancer are safe but are they beneficial. Med Oncol. 2015;32(6):175. doi:10.1007/s12032-015-0622-y. Abtahian F, Hawkins BM, Ryan DP, et al. Inferior vena cava filter usage, complications, and retrieval rate in cancer patients. Am J Med. 2014;127(11):1111‐1117. doi:10.1016/j.amjmed.2014.06.025. Stein PD, Matta F, Sabra MJ. Case fatality rate with vena cava filters in hospitalized stable patients with cancer and pulmonary embolism. Am J Med. 2013;126(9):819‐824. doi:10.1016/j.amjmed.2013.03.030. Makary MS, Koso M, Yoder M. Utility and clinical outcomes of perioperative inferior vena cava filter prophylaxis in spine surgery patients. Spine. 2023;49:569‐576. doi:10.1097/BRS.0000000000004670. Body mass index, BMI calculator, healthy BMI. National Heart Lung and Blood Institute. Accessed October 9, 2021. https://www.nhlbi.nih.gov/health/educational/lose_wt/bmitools.htm. Doyle DJ, Goyal A, Bansal P, Garmon EH. American Society of Anesthesiologists Classification. In: StatPearls. StatPearls Publishing; July 7, 2021. Omary RA, Bettmann MA, Cardella JF, et al. Quality improvement guidelines for the reporting and archiving of interventional radiology procedures. J Vasc Interv Radiol. 2003;14(9 pt 2):S293‐S295. doi:10.1097/01.rvi.0000094601.83406.e1. Mattiuzzi C, Lippi G. Current cancer epidemiology. J Epidemiol Glob Health. 2019;9(4):217‐222. doi:10.2991/jegh.k.191008.001. PREPIC Study Group. Eight‐year follow‐up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation. 2005;112(3):416‐422. doi:10.1161/CIRCULATIONAHA.104.512834. Narayan A, Hong K, Streiff M, et al. The impact of cancer on the clinical outcome of patients after inferior vena cava filter placement. Am J Clin Oncol. 2016;39(3):294‐301. doi:10.1097/COC.0000000000000062. Shinagare AB, Guo M, Hatabu H, et al. Incidence of pulmonary embolism in oncologic outpatients at a tertiary cancer center. Cancer. 2011;117(16):3860‐3866. doi:10.1002/cncr.25941. Gimbel IA, Mulder FI, Bosch FTM, et al. Pulmonary embolism at autopsy in cancer patients. J Thromb Haemost. 2021;19(5):1228‐1235. doi:10.1111/jth.15250. |
| فهرسة مساهمة: | Keywords: IVC filters; PE; VTE; cancer; perioperative; surgery |
| تواريخ الأحداث: | Date Created: 20240612 Date Completed: 20240801 Latest Revision: 20240801 |
| رمز التحديث: | 20240801 |
| DOI: | 10.1002/jso.27734 |
| PMID: | 38865285 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!